Macrophage and TGF-β immunohistochemical expression in Jorge Lobo's disease

Human Pathology

Volumn 39, Issue 2, 2008, Pages 269-274

  Xavier, Marilia Brasil ^a   Libonati, Rosana Maria Feio ^a   Unger, Débora ^a   Oliveira, Clívia ^a   Corbett, Carlos Eduardo Pereira ^b   de Brito, Arival Cardoso ^a   Quaresma, Juarez Antonio Simões ^a  

^a FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokine; Immunopathology; Lacazia loboi; Lacaziosis

Indexed keywords

CD86 ANTIGEN; COLLAGEN; CYTOKINE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ANTIBODY LABELING; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; KELOID; KELOIDAL BLASTOMYCOSIS; LACAZIA LOBOI; LACAZIOSIS; MACROPHAGE; MALE; MYCOSIS;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MIDDLE AGED; PARACOCCIDIOIDES; PARACOCCIDIOIDOMYCOSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 38149022501     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.06.016     Document Type: Article

References (30)

1. Taborda P.R., Taborda V.A., and McGinnis M.R. Lacazia loboi gen.nov., comb. nov., the etiologic agent of lobomycosis. J Clin Microbiol 37 (1999) 2031-2033
2. Herr R.A., Tarcha E.J., Taborda P.R., Taylor J.W., Ajello L., and Mendoza L. Phylogenetic analysis of Lacazia loboi places this previously uncharacterized pathogen within the dimorphic Onygenales. J Clin Microbiol 39 (2001) 309-314
3. Baruzzi R.G., Lacaz C.S., and Souza F.A.A. História natural da doença de Jorge Lobo. Ocorrência entre os índios Caiabí (Brasil Central). Rev Inst Med Trop S Paulo 21 (1979) 302-338
4. Opromolla D.V.A., Madeira S., Belone A.F.F., and Vilani-Moreno F.R. Jorge Lobo's experimental inoculation in Swiss mice. Rev Inst Med Trop S Paulo 41 (1999) 359-364
5. Opromolla D.V.A., Belone A.F.F., Taborda P.R.O., and Taborda V.B.A. Correlação clinicopatológica em 40 casos novos de lobomicose. An Brás Dermatol 75 (2000) 425-434
6. Rodriguez-Toro G. Lobomycosis. Int J Dermatol 32 (1993) 324-332
7. Pecher S.A., Croce J., and Ferri R.G. Study of humoral and cellular immunity in lobomycosis. Al1ergol Immunopath 7 (1979) 439-444
8. Vilani-Moreno F.R., Belone A.F., Soares C.T., and Opromolla D.V. Immunohistochemical characterization of the cellular infiltrate in Jorge Lobo's disease. Rev Iberoam Micol 22 (2005) 44-49
9. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N Engl J Med 342 (2000) 1350-1358
10. Lebman D.A., and Edmiston J.S. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect 1 (1999) 1297-1304
11. Reed S.G. TGF-beta in infections and infectious diseases. Microbes Infect 1 (1999) 1313-1325
12. Hall B.S., and Pereira M.A. Dual role for transforming growth factor beta-dependent signaling in Trypanosoma cruzi infection of mammalian cells. Infect Immun 68 (2000) 2077-2081
13. Gantt K.R., Schultz-Cherry S., Rodriguez N., et al. Activation of TGF-beta by Leishmania chagasi: importance for parasite survival in macrophages. J Immunol 170 (2003) 2613-2620
14. Schuppan D., Krebs A., Bauer M., and Hahn E.G. Hepatitis C and liver fibrosis. Cell Death Differ 1 (2003) S59-S67
15. Wang H., Mengsteab S., Tag C.G., et al. Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 7 (2005) 1929-1936
16. Hsu S.M., Raine L., and Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedure. J Histochem Cytochem 29 (1981) 577-580
17. Baruzzi R.G., Castro R.M., D'Andretta C., Carvalhal S., Ramos O.L., and Pontes P.L. Occurrence of Lobo's blastomycosis among "Caiabi" Brazilian Indians. Int J Dermatol 12 (1973) 95-98
18. Baruzzi R.G., Marcopito L.F., Vicente L.S., and Michalany N.S. Jorge Lobo's disease (keloidal blastomycosis) and tinea imbricata in Indians from the Xingu National Park, Central Brazil. Trop Doctor 12 (1982) 13-15
19. D'Ávila S.C.G.P., Pagliari C., and Duarte M.I.S. The cell-mediated immune reaction in the cutaneous lesion of chromoblastomycosis and their correlation with different clinical forms of the disease. Mycopathol 156 (2003) 51-60
20. Xavier M.B., Ferreira M.M., Quaresma J.A.S., and Brito A.C. HIV and lacaziosis, Brazil. Emerg Infect Dis 12 (2006) 526-527
21. Weiss L.M., Arber D.A., and Chang K.L. CD68: a review. Appl Immunohistochem 2 (1994) 2-8
22. Flisiak R., Prokopowicz D., Jaroszewicz J., and Flisiak I. Plasma transforming growth factor-beta(1) in acute viral hepatitis. Med Sci Monit 11 (2005) 304-308
23. Quaresma J.A.S., Barros V.L.R.S., Fernandes E.R., et al. Reconsideration of histopathology and ultrastructural aspects of the human liver in yellow fever. Acta Trop 94 (2005) 116-127
24. Quaresma J.A.S., Barros V.L.R.S., Pagliari C., et al. Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity. Virol 345 (2006) 22-30
25. Verrecchia F., and Mauviel A. Transforming growth factor-β signaling through the smad pathway: role in extracellular matrix gene expression and regulation. J Invest Dermatol 118 (2002) 211-215
26. Branton M.H., and Kopp J.B. TGF-beta and fibrosis: microbes. Infect 1 (1999) 1349-1365
27. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., and Gauthier J.M. Direct biding of samad3 and samad4 to critical TGF-beta-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 17 (1998) 3091-3100
28. Imamura T., Takase M., Nishihara A., et al. Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389 (1997) 622-626
29. Parise-Fortes M.R., Marques S.A., Soares A.M., Kurokawa C.S., Marques M.E., and Peracoli M.T. Cytokines release from blood monocytes and expressed in mucocutaneous lesions of patients with paracoccidioidomycosis evaluated before and during trimethoprim-sulfamethoxazole treatment. Br J Dermatol 154 (2006) 643-650
30. Marshall B.G., Wangoo A., Cook H.T., and Shaw R.J. Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis. Thorax 52 (1997) 588-591